| Schedule of changes in consolidated equity |
The following table shows the changes in consolidated equity during the three months ended March 31, 2018 and 2017 (dollars in millions, share amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Tenet Healthcare Corporation Shareholders’ Equity | | | | | | | Common Stock | | Additional
Paid-In
Capital | | Accumulated
Other
Comprehensive
Loss | | Accumulated
Deficit | | Treasury
Stock | | Noncontrolling
Interests | | Total Equity | | | Shares
Outstanding | | Issued Par
Amount | | | | | | | Balances at December 31, 2017 | | 100,972 |
| | $ | 7 |
| | $ | 4,859 |
| | $ | (204 | ) | | $ | (2,390 | ) | | $ | (2,419 | ) | | $ | 686 |
| | $ | 539 |
| Net income | | — |
| | — |
| | — |
| | — |
| | 99 |
| | — |
| | 31 |
| | 130 |
| Distributions paid to noncontrolling interests | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (34 | ) | | (34 | ) | Other comprehensive income | | — |
| | — |
| | — |
| | 8 |
| | — |
| | — |
| | — |
| | 8 |
| Accretion of redeemable noncontrolling interests | | — |
| | — |
| | (37 | ) | | — |
| | — |
| | — |
| | — |
| | (37 | ) | Purchases (sales) of businesses and noncontrolling interests | | — |
| | — |
| | (4 | ) | | — |
| | — |
| | — |
| | (2 | ) | | (6 | ) | Cumulative effect of accounting change | | — |
| | — |
| | — |
| | (43 | ) | | 43 |
| | — |
| | — |
| | — |
| Stock-based compensation expense, tax benefit and issuance of common stock | | 1,017 |
| | — |
| | 15 |
| | — |
| | — |
| | 1 |
| | — |
| | 16 |
| Balances at March 31, 2018 | | 101,989 |
| | $ | 7 |
| | $ | 4,833 |
| | $ | (239 | ) | | $ | (2,248 | ) | | $ | (2,418 | ) | | $ | 681 |
| | $ | 616 |
| | | | | | | | | | | | | | | | | | Balances at December 31, 2016 | | 99,686 |
| | $ | 7 |
| | $ | 4,827 |
| | $ | (258 | ) | | $ | (1,742 | ) | | $ | (2,417 | ) | | $ | 665 |
| | $ | 1,082 |
| Net income (loss) | | — |
| | — |
| | — |
| | — |
| | (53 | ) | | — |
| | 36 |
| | (17 | ) | Distributions paid to noncontrolling interests | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (36 | ) | | (36 | ) | Other comprehensive income | | — |
| | — |
| | — |
| | 3 |
| | — |
| | — |
| | — |
| | 3 |
| Purchases (sales) of businesses and noncontrolling interests | | — |
| | — |
| | 4 |
| | — |
| | — |
| | — |
| | (1 | ) | | 3 |
| Cumulative effect of accounting change | | — |
| | — |
| | — |
| | — |
| | 56 |
| | — |
| | — |
| | 56 |
| Stock-based compensation expense and issuance of common stock | | 735 |
| | — |
| | 3 |
| | — |
| | — |
| | — |
| | — |
| | 3 |
| Balances at March 31, 2017 | | 100,421 |
| | $ | 7 |
| | $ | 4,834 |
| | $ | (255 | ) | | $ | (1,739 | ) | | $ | (2,417 | ) | | $ | 664 |
| | $ | 1,094 |
|
|